Arvinas Inc logo

Arvinas Inc

ARVN
Healthcare|Biotechnology|USA
$8.28
-0.27 (-3.10%)
Tangible Book
$6.00

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 116.12, 62.96, 80.79, 130.45, 190.7 ], "ebit_estimate": [ -204.64, -275.96, -256.18, -225.89, -161.97 ], "ebitda_estimate": [ -182.09, -253.97, -202.85, null, null ], "net_income_estimate": [ -177.86, -249.98, -230.68, -207.75, -171.41 ], "per_share_eps_estimate": [ -2.88, -3.6, -3.19, -2.32, -1.51 ], "eps_nri_estimate": [ -2.88, -3.46, -3.07, -2.32, -1.51 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 4.2, 4, -0.31, null, null ], "pretax_income_estimate": [ -185.4, -250.36, -236.67, -211.34, -147.41 ], "operating_cash_flow_per_share_estimate": [ -1.92, -3.8, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ -35.86, -72.43, -194.35, null, null ], "gross_margin_estimate": [ 100, 100, 100, 100, 100 ], "operating_cash_flow_estimate": [ -122.88, -243.2, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0 ], "long_term_growth_rate_mean": -37.09, "long_term_revenue_growth_rate_mean": "-33.96", "future_per_share_eps_estimate_growth": -39.28, "future_eps_nri_estimate_growth": -37.09, "future_revenue_estimate_growth": -33.96, "future_ebit_estimate_growth": -29.85, "future_ebitda_estimate_growth": -22.41, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -41.73, "future_pretax_income_estimate_growth": -42.41, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": -125.95, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 35.95, 29.98, 27.79, 10.74, 11.56, 12.06, 14.02 ], "ebit_estimate": [ -27.67, -55.66, -61.13, -66.03, -66.26, -66.5, -66.58 ], "ebitda_estimate": [ -0.86, -60.61, -75.59, null, null, null, null ], "net_income_estimate": [ -29.67, -50.34, -54.08, -59.66, -62.46, -62.94, -63.46 ], "per_share_eps_estimate": [ -0.41, -0.77, -0.81, -0.96, -0.97, -0.92, -0.88 ], "eps_nri_estimate": [ -0.42, -0.77, -0.79, -0.96, -0.97, -0.92, -0.88 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -39.39, -47.58, -51.44, -59.66, -62.46, -62.94, -63.46 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ -42.08, -35.2, -41.07, null, null, null, null ], "gross_margin_estimate": [ 100, 100, 100, 100, 100, 100, 100 ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": -37.09, "long_term_revenue_growth_rate_mean": "-33.96", "future_per_share_eps_estimate_growth": -39.28, "future_eps_nri_estimate_growth": -37.09, "future_revenue_estimate_growth": -33.96, "future_ebit_estimate_growth": -29.85, "future_ebitda_estimate_growth": -22.41, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -41.73, "future_pretax_income_estimate_growth": -42.41, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": -125.95, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

News

2026-06-24 17:00:08